T1	Entity 0 4	ESR1
T2	Entity 9 12	EGF
T3	SNP 13 30	genetic variation
T4	Association 31 45	in relation to
E1	Association:T4 bc:T5 snp_int:T3 snp_int2:T10
T5	Cancer 46 59	breast cancer
T6	Other_effect 69 77	survival
E2	Other_effect:T6 Agent:T3 Theme:T5
R2	SNP_coupled_gene Arg1:T3 Arg2:T1	
T7	Entity 156 180	Oestrogen receptor alpha
R3	Equiv Arg1:T7 Arg2:T1	
A1	SNP_Class T3 Common_variant
T8	SNP 356 373	genetic variation
T9	Entity 381 385	ESR1
T10	SNP 13 30	genetic variation
R1	SNP_coupled_gene Arg1:T10 Arg2:T2	
A2	SNP_Class T10 Common_variant
R4	SNP_coupled_gene Arg1:T8 Arg2:T9	
T11	SNP 356 373	genetic variation
T12	Entity 390 393	EGF
R5	SNP_coupled_gene Arg1:T11 Arg2:T12	
T13	Association 400 407	affects
E3	Association:T13 bc:T15 snp_int:T11 snp_int2:T8
T14	Spec 346 348	if
R6	Speculation_marker Arg1:E3 Arg2:T14	
T15	Cancer 408 421	breast cancer
T16	Cell_types_tissues_affected 435 450	characteristics
E4	Cell_types_tissues_affected:T16 Theme:T17 Agent:T11 Agent2:T8
T17	Entity 428 434	tumour
R7	Speculation_marker Arg1:E4 Arg2:T14	
T18	Other_effect 468 476	survival
E5	Other_effect:T18 Agent:T11 Agent2:T8 Theme:T15
R8	Speculation_marker Arg1:E5 Arg2:T14	
T19	Entity 567 574	Swedish
R9	Population_assignment Arg1:T8 Arg2:T19	
R10	Population_assignment Arg1:T11 Arg2:T19	
A3	SNP_Class T11 Common_variant
A4	SNP_Class T8 Common_variant
T20	SNP 1214 1223	rs3003925
T21	SNP 1228 1237	rs2144025
T22	Entity 1200 1204	ESR1
R11	SNP_coupled_gene Arg1:T20 Arg2:T22	
R12	SNP_coupled_gene Arg1:T21 Arg2:T22	
T23	Association 1243 1254	association
E6	Association:T23 snp_int:T20 snp_int2:T21 bc:T25
T24	Spec 1178 1187	suggested
R13	Speculation_marker Arg1:E6 Arg2:T24	
T25	Cancer 1260 1273	breast cancer
T26	Level 1514 1517;1528 1534	not strong
T27	Spec 1518 1525	support
T28	Association 1535 1546	association
E7	Association:T28 snp_int:T31 snp_int2:T29 bc:T33
A5	Level E7 Low
R14	Level_marker Arg1:E7 Arg2:T26	
R15	Speculation_marker Arg1:E7 Arg2:T27	
T29	SNP 1562 1570	variants
T30	Entity 1578 1582	ESR1
T31	SNP 1562 1570	variants
A6	SNP_Class T31 Common_variant
A7	SNP_Class T29 Common_variant
T32	Entity 1587 1590	EGF
T33	Cancer 1601 1614	breast cancer
R16	Equiv Arg1:E7 Arg2:E1	
R17	SNP_coupled_gene Arg1:T29 Arg2:T32	
R18	SNP_coupled_gene Arg1:T31 Arg2:T30	
T34	Cell_types_tissues_affected 1628 1643	characteristics
E8	Cell_types_tissues_affected:T34 Theme:T35 Agent:T29 Agent2:T31
T35	Entity 1621 1627	tumour
T36	Other_effect 1647 1655	survival
E9	Other_effect:T36 Agent:T31 Agent2:T29 Theme:T33
R19	Speculation_marker Arg1:E9 Arg2:T27	
R20	Speculation_marker Arg1:E8 Arg2:T27	
R21	Level_marker Arg1:E8 Arg2:T26	
R22	Level_marker Arg1:E9 Arg2:T26	
A8	Level E8 Low
A9	Level E9 Low
R23	Population_assignment Arg1:T20 Arg2:T19	
R24	Population_assignment Arg1:T21 Arg2:T19	
R25	Population_assignment Arg1:T31 Arg2:T19	
R26	Population_assignment Arg1:T29 Arg2:T19	
